
Pharmacally
Breast Cancer
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Breast Cancer
New Drug ApprovalFDA Clears VEPPANU, First PROTAC Therapy, for Advanced Breast CancerVEPPANU (vepdegestrant), developed by Arvinas and Pfizer, becomes the first approved PROTAC therapy, demonstrating significant progression-free survival benefit in ESR1-mutated ER+/HER2- advanced breast cancer.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.